ADC Therapeutics (ADCT) Amortizatization of Intangibles (2023 - 2026)

ADC Therapeutics has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $6.8 million for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $6.8 million, down 3.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $941000.0 (down 96.69% YoY), and the FY2025 annual result was $1.2 million, down 95.85% from the prior year.
• Amortizatization of Intangibles came in at $6.8 million for Q1 2026 at ADC Therapeutics, up from $113000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $26.7 million in Q4 2024 to a low of -$12.9 million in Q3 2025.
• The 4-year median for Amortizatization of Intangibles is $6.8 million (2026), against an average of $4.3 million.
• Peak annual rise in Amortizatization of Intangibles reached 697.21% in 2024, while the deepest fall reached 4331.88% in 2024.
• ADC Therapeutics' Amortizatization of Intangibles stood at $7.2 million in 2023, then jumped by 273.59% to $26.7 million in 2024, then sank by 99.58% to $113000.0 in 2025, then jumped by 5952.21% to $6.8 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $6.8 million (Q1 2026), $113000.0 (Q4 2025), and -$12.9 million (Q3 2025), per Business Quant data.